Citation: M. Bonacini et al., Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus, J ACQ IMM D, 26(4), 2001, pp. 340-344
Authors:
Lin, HJ
Seeff, LB
Barbosa, L
Hollinger, FB
Citation: Hj. Lin et al., Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: Divergenceover time, HEPATOLOGY, 34(2), 2001, pp. 424-429
Authors:
Seeff, LB
Hollinger, FB
Alter, HJ
Wright, EC
Cain, CMB
Buskell, ZJ
Ishak, KG
Iber, FL
Toro, D
Samanta, A
Koretz, RL
Perrillo, RP
Goodman, ZD
Knodell, RG
Gitnick, G
Morgan, TR
Schiff, ER
Lasky, S
Stevens, C
Vlahcevic, RZ
Weinshel, E
Tanwandee, T
Lin, HJ
Barbosa, L
Citation: Lb. Seeff et al., Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A national heart, lung, and blood institute collaborative study, HEPATOLOGY, 33(2), 2001, pp. 455-463
Authors:
Lin, HJ
Siwak, EB
Lander, IJ
Hollinger, FB
Citation: Hj. Lin et al., Long-term culture of human immunodeficiency virus type 1 resulting in lossof glycosylation sites, J MED VIROL, 63(3), 2001, pp. 197-202
Authors:
Harris, DR
Gonin, R
Alter, HJ
Wright, EC
Buskell, ZJ
Hollinger, FB
Seeff, LB
Citation: Dr. Harris et al., The relationship of acute transfusion-associated hepatitis to the development of cirrhosis in the presence of alcohol abuse, ANN INT MED, 134(2), 2001, pp. 120-124
Citation: Eb. Keeffe et al., Genotype does not affect pattern of HCV RNA decrease among responders during interferon treatment of chronic hepatitis C, CYTOK CELL, 5(4), 1999, pp. 211-216
Authors:
Pockros, PJ
Bain, VG
Hunter, EB
Conrad, A
Balart, A
Hollinger, FB
Albert, D
Citation: Pj. Pockros et al., A comparison of reverse transcription polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment, J VIRAL HEP, 6(2), 1999, pp. 145-150
Authors:
Lavanchy, D
Purcell, R
Hollinger, FB
Howard, C
Alberti, A
Kew, M
Dusheiko, G
Alter, M
Ayoola, E
Beutels, P
Bloomer, R
Ferret, B
Decker, R
Esteban, R
Fay, O
Fields, H
Fuller, EC
Grob, P
Houghton, M
Leung, N
Locarnini, SA
Margolis, H
Meheus, A
Miyamura, T
Mohamed, MK
Tandon, B
Thomas, D
Head, HT
Toukan, AU
Van Damme, P
Zanetti, A
Arthur, R
Couper, M
D'Amelio, R
Emmanuel, JC
Esteves, K
Gavinio, P
Griffiths, E
Hallaj, Z
Heuck, CC
Heymann, DL
Holck, SE
Kane, M
Martinez, LJ
Meslin, F
Mochny, IS
Ndikuyeze, A
Padilla, AM
Rodier, GRM
Roure, C
Savage, F
Vercauteren, G
Citation: D. Lavanchy et al., Global surveillance and control of hepatitis C, J VIRAL HEP, 6(1), 1999, pp. 35-47
Authors:
Jensen, DM
Krawitt, EL
Keeffe, EB
Hollinger, FB
James, SP
Mullen, K
Everson, GT
Hoefs, JC
Fromm, H
Black, M
Foust, RT
Pimstone, PR
Heathcote, EJL
Albert, D
Citation: Dm. Jensen et al., Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: Effect of baseline viral concentration, AM J GASTRO, 94(12), 1999, pp. 3583-3588